Cartesian Therapeutics (RNAC) EBITDA Margin Growth (3y) (2018 - 2026)
Cartesian Therapeutics (RNAC) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
-4.99 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-4.99 Mn |
| Dec 31, 2025 |
634,887.00 |
| Sep 30, 2025 |
-790,678.00 |
| Mar 31, 2025 |
-169,164.00 |
| Dec 31, 2024 |
69,414.00 |
| Sep 30, 2024 |
-617,945.00 |
| Jun 30, 2024 |
1,835.00 |
| Mar 31, 2024 |
-75,044.00 |
| Dec 31, 2023 |
-202,000.00 |
| Sep 30, 2023 |
7,238.00 |
| Dec 31, 2022 |
25,852.00 |
| Jun 30, 2022 |
12.61 Mn |
| Mar 31, 2022 |
12.06 Mn |
| Dec 31, 2021 |
166,777.00 |
| Dec 31, 2020 |
11.49 Mn |
| Sep 30, 2020 |
5.41 Mn |
| Dec 31, 2019 |
25,582.00 |
| Jun 30, 2019 |
-12.57 Mn |
| Mar 31, 2019 |
-12.02 Mn |
| Dec 31, 2018 |
-128,970.00 |
